Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inho Kim

Showing results (341-350 of 347) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 347 results.
Annals of Hematology|May 22, 2026
Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemiaSeok Lee, Hyeoung-Joon Kim, June-Won Cheong, et al.
American Journal of Hematology|August 1, 2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemiaSung-Nam Lim, Young-Don Joo, Kyoo-Hyung Lee, et al.
Blood Research|June 9, 2022
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in KoreaSeo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, et al.
Cancer Medicine|March 27, 2018
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKoreaJunghoon Shin, Youngil Koh, Seo Hyun Yoon, et al.
The Korean Journal of Internal Medicine|July 11, 2022
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemiaYoung Hoon Park, Dae-Young Kim, Yeung-Chul Mun, et al.
Blood|June 13, 2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaDae-Young Kim, Young-Don Joo, Sung-Nam Lim, et al.
Orphanet Journal of Rare Diseases|May 25, 2019
Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyteHyoung Soo Choi, Qute Choi, Jung-Ah Kim, et al.
Pageof 35

Showing results (341-350 of 347) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 347 results.
Annals of Hematology|May 22, 2026
Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemiaSeok Lee, Hyeoung-Joon Kim, June-Won Cheong, et al.
American Journal of Hematology|August 1, 2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemiaSung-Nam Lim, Young-Don Joo, Kyoo-Hyung Lee, et al.
Blood Research|June 9, 2022
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in KoreaSeo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, et al.
Cancer Medicine|March 27, 2018
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKoreaJunghoon Shin, Youngil Koh, Seo Hyun Yoon, et al.
The Korean Journal of Internal Medicine|July 11, 2022
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemiaYoung Hoon Park, Dae-Young Kim, Yeung-Chul Mun, et al.
Blood|June 13, 2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaDae-Young Kim, Young-Don Joo, Sung-Nam Lim, et al.
Orphanet Journal of Rare Diseases|May 25, 2019
Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyteHyoung Soo Choi, Qute Choi, Jung-Ah Kim, et al.
Pageof 35